BIO-Europe

A jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed in a patent dispute between Maquet Cardiovascular and Abiomed.

The Uppsala site has been established to support scientific collaboration, application development and resin innovation.

Last month, The Life Science Cluster attracted a record number of investors to its annual Investor Partnering Day in Oslo. Interest in life sciences is clearly growing. But why and why now?

Skape Bio and researchers at the University of Washington’s Institute for Protein Design (IPD) have announced a peer-reviewed study published in Nature demonstrating a new way to design protein-based medicines for G protein-coupled receptors, or GPCRs.

The new center in Freiburg is dedicated to the development and production of quality-critical materials for the cell and gene therapy market.

The two companies have partnered to offer an integrated development and manufacturing pathway for recombinant protein programs in E. coli.

The agreement for distribution and commercialization of Pepaxti in Central and Eastern Europe addresses a market potential of approximately SEK 150 million and enables potential sales uptake in this region earlier than previously planned, the company states.